📰 Michael Mcelhaugh News
Michael Mcelhaugh News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Mcelhaugh. Real-time updates on events, politics, business and more.
April 4, 2024
(RTTNews) - Arbutus Biopharma (ABUS) issued statement regarding the claim construction ruling of the U.S. District Court for the District of Delaw...
March 1, 2024
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript February 29, 2024 Arbutus Biopharma Corporation reports earnings inline with expectations. Reported EPS is $-0.12 EPS, expectations were $-0.12. ABUS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and […]
March 6, 2023
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Conference Call.